mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-06 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-06 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
4e-06 |